Epigenetic regulation of epithelial to mesenchymal transition by the Lysine specific demethylase LSD1/KDM1A

被引:46
|
作者
Ambrosio, Susanna [1 ]
Sacca, Carmen D. [1 ]
Majello, Barbara [1 ]
机构
[1] Univ Naples Federico II, Dept Biol, Naples, Italy
关键词
EMT; LSD1; Chromatin; Cell migration and invasion; Cancer; HISTONE DEMETHYLASE; TRANSCRIPTIONAL REPRESSION; LSD1; CANCER; METASTASIS; INHIBITION; PHOSPHORYLATION; COREST; GENES; EMT;
D O I
10.1016/j.bbagrm.2017.07.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Lysine-specific demethylase 1, KDM1A/LSD1, plays a central role in the regulation of Pol II transcription through the removal of the activation mark (mono- and dimethyl lysine 4 of histone H3). LSD1 is often deregulated in human cancers, and it is frequently overexpressed in human solid cancers and leukemia. LSD1 regulates the epithelial mesenchymal transition (EMT) in epithelial cells, i.e., the ability to transition into mesenchymal cells, to lose homotypic adhesion and to acquire migratory capacity. From its initial discovery as a component of the Snail complex, multiple studies highlighted the causative role of LSD1 in cell invasiveness and EMT, describing its direct involvement in different molecular processes through the interaction with specific partners. Here we present an overview of the role of LSD1 in the EMT process, summarizing recent findings on its emerging functions in cell migration and invasion in cancer.
引用
收藏
页码:905 / 910
页数:6
相关论文
共 50 条
  • [41] Lysine-specific demethylase 1 (LSD1) in hematopoietic and lymphoid neoplasms
    Niebel, Dennis
    Kirfel, Jutta
    Janzen, Viktor
    Hoeller, Tobias
    Majores, Michael
    Guetgemann, Ines
    BLOOD, 2014, 124 (01) : 151 - 152
  • [42] Regulation of Lipogenic Gene Expression by Lysine-specific Histone Demethylase-1 (LSD1)
    Abdulla, Arian
    Zhang, Yi
    Hsu, Fu-Ning
    Xiaoli, Alus M.
    Zhao, Xiaoping
    Yang, Ellen S. T.
    Ji, Jun-Yuan
    Yang, Fajun
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (43) : 29937 - 29947
  • [43] Lysine-specific demethylase 1 (LSD1) in hematopoietic and lymphoid neoplasms
    Niebel, D.
    Kirfel, J.
    Janzen, V.
    Hoeller, T.
    Majores, M.
    Guetgemann, I.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 282 - 283
  • [44] Recent advances of LSD1/KDM1A inhibitors for disease therapy
    Zhang, Chaofeng
    Wang, Zhiyuan
    Shi, Yuting
    Yu, Bin
    Song, Yihui
    BIOORGANIC CHEMISTRY, 2023, 134
  • [45] KDM1A/LSD1 regulates the differentiation and maintenance of spermatogonia in mice
    Myrick, Dexter A.
    Christopher, Michael A.
    Scott, Alyssa M.
    Simon, Ashley K.
    Donlin-Asp, Paul G.
    Kelly, William G.
    Katz, David J.
    PLOS ONE, 2017, 12 (05):
  • [46] Capsaicin: A "hot" KDM1A/LSD1 inhibitor from peppers
    Jia, Gang
    Cang, Shundong
    Ma, Peizhi
    Song, Zhiyu
    BIOORGANIC CHEMISTRY, 2020, 103
  • [47] LSD1 (KDM1A)-independent effects of the LSD1 inhibitor SP2509 in cancer cells
    Sonnemann, Juergen
    Zimmermann, Miriam
    Marx, Christian
    Ebert, Franziska
    Becker, Sabine
    Lauterjung, Marie-Luise
    Beck, James F.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (03) : 494 - 497
  • [48] LSD1/KDM1A inhibitors in clinical trials: advances and prospects
    Yuan Fang
    Guochao Liao
    Bin Yu
    Journal of Hematology & Oncology, 12
  • [49] Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma
    Alejo, Salvador
    Palacios, Bridgitte E.
    Venkata, Prabhakar Pitta
    He, Yi
    Li, Wenjing
    Johnson, Jessica D.
    Chen, Yihong
    Jayamohan, Sridharan
    Pratap, Uday P.
    Clarke, Kyra
    Zou, Yi
    Lv, Yingli
    Weldon, Korri
    Viswanadhapalli, Suryavathi
    Lai, Zhao
    Ye, Zhenqing
    Chen, Yidong
    Gilbert, Andrea R.
    Suzuki, Takayoshi
    Tekmal, Rajeshwar R.
    Zhao, Weixing
    Zheng, Siyuan
    Vadlamudi, Ratna K.
    Brenner, Andrew J.
    Sareddy, Gangadhara R.
    NEURO-ONCOLOGY, 2023, 25 (07) : 1249 - 1261
  • [50] LSD1/KDM1A inhibitors in clinical trials: advances and prospects
    Fang, Yuan
    Liao, Guochao
    Yu, Bin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)